| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.37B | 62.87B | 64.23B | 67.14B | 63.78B | 59.18B |
| Gross Profit | 14.00B | 13.62B | 13.92B | 13.72B | 12.28B | 10.50B |
| EBITDA | 5.72B | 5.55B | 5.96B | 5.34B | 3.90B | 3.04B |
| Net Income | 3.13B | 3.25B | 2.04B | 3.78B | 1.31B | 407.00M |
Balance Sheet | ||||||
| Total Assets | 86.77B | 88.05B | 86.80B | 89.20B | 83.81B | 84.47B |
| Cash, Cash Equivalents and Short-Term Investments | 5.94B | 5.97B | 4.95B | 5.74B | 4.44B | 6.10B |
| Total Debt | 24.30B | 24.46B | 23.50B | 26.46B | 26.12B | 28.13B |
| Total Liabilities | 50.56B | 51.36B | 52.22B | 57.90B | 57.66B | 59.67B |
| Stockholders Equity | 36.21B | 36.69B | 34.57B | 31.04B | 25.50B | 23.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 560.00M | 2.11B | 1.55B | 601.00M | 1.21B |
| Operating Cash Flow | 0.00 | 2.42B | 3.43B | 3.13B | 1.92B | 2.83B |
| Investing Cash Flow | 0.00 | -1.65B | -301.00M | -1.69B | -1.50B | 54.00M |
| Financing Cash Flow | 0.00 | -31.00M | -3.97B | -405.00M | -2.29B | -3.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥256.39B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥112.14B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
78 Outperform | ¥30.65B | 5.62 | ― | 5.69% | >-0.01% | 65.65% | |
77 Outperform | ¥90.37B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥200.50B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
76 Outperform | ¥116.37B | 0.96 | ― | 1.43% | -1.38% | 327.52% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |